BRIEF

on ARCHOS (EPA:ALJXR)

Dextrain’s HomeRehab unveiled at GEM 2024

Stock price chart of ARCHOS (EPA:ALJXR) showing fluctuations.

Dextrain, a subsidiary of ARCHOS, announces its participation in the GEM 2024 trade show in Paris, from December 19 to 21. This congress is an opportunity to present HomeRehab, an innovative solution for post-stroke rehabilitation. This innovative device is now on sale on the company's website.

The HomeRehab integrates individual force sensors to assess each finger. Interactive software allows exercises to be personalized according to the needs of patients. This system combines fun tools and immediate feedback to stimulate and monitor users' progress.

Visitors to GEM 2024 will be able to test HomeRehab through interactive demonstrations and meet the Dextrain team to discuss the possibilities offered by this tool.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all ARCHOS news